Literature DB >> 1419002

Disrupted cerebellar cortical development and progressive degeneration of Purkinje cells in SV40 T antigen transgenic mice.

R M Feddersen1, R Ehlenfeldt, W S Yunis, H B Clark, H T Orr.   

Abstract

SV40 T antigen (Tag) expression directed to cerebellar Purkinje cells resulted in the generation of three transgenic mouse lines that displayed ataxia, a neurological phenotype characteristic of cerebellar dysfunction. Onset of symptoms and cerebellar pathology, characterized by specific Purkinje cell degeneration, appeared to be directly dependent upon transgene copy number. The SV5 line (containing > 30 transgene copies), exhibited embryonic transgene expression that caused selective death of immature Purkinje cells and a subsequent block in cerebellar development and ataxia at 2 weeks. The developmental effect of the disruption of Purkinje cells in SV5 mice suggests that a normal complement of these cells is required for early development of the cerebellar cortex, especially granule cell proliferation and migration from external to internal layers. Transgene expression in a second line, SV4 (10 copies), was detectable during the second postnatal week. Death of mature Purkinje cells in the SV4 line resulted in onset of ataxia at 9 weeks. Ataxia in a third line, SV6 (2 copies), was detected after 15 weeks. The distinct cerebellar phenotypes of the SV4-6 lines correlate with specific Tag-induced Purkinje cell ablation as opposed to tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1419002     DOI: 10.1016/0896-6273(92)90247-b

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  62 in total

1.  DNA replication precedes neuronal cell death in Alzheimer's disease.

Authors:  Y Yang; D S Geldmacher; K Herrup
Journal:  J Neurosci       Date:  2001-04-15       Impact factor: 6.167

2.  Afferent-target cell interactions in the cerebellum: negative effect of granule cells on Purkinje cell development in lurcher mice.

Authors:  M L Doughty; A Lohof; F Selimi; N Delhaye-Bouchaud; J Mariani
Journal:  J Neurosci       Date:  1999-05-01       Impact factor: 6.167

Review 3.  Nuclear ataxias.

Authors:  Harry T Orr
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-05       Impact factor: 10.005

4.  cDNA microarray analysis of gene expression in the cerebral cortex and hippocampus of BALB/c mice subjected to chronic mild stress.

Authors:  Yanyong Liu; Nan Yang; Pingping Zuo
Journal:  Cell Mol Neurobiol       Date:  2010-06-09       Impact factor: 5.046

5.  Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain.

Authors:  I Vincent; G Jicha; M Rosado; D W Dickson
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

Review 6.  Oxidative stress, cell cycle, and neurodegeneration.

Authors:  Jeffrey A Klein; Susan L Ackerman
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

Review 7.  Genetic targeting of cerebellar Purkinje cells: history, current status and novel strategies.

Authors:  Jaroslaw J Barski; Matthias Lauth; Michael Meyer
Journal:  Cerebellum       Date:  2002-04       Impact factor: 3.847

Review 8.  Pathological implications of cell cycle re-entry in Alzheimer disease.

Authors:  David J Bonda; Hyun-pil Lee; Wataru Kudo; Xiongwei Zhu; Mark A Smith; Hyoung-gon Lee
Journal:  Expert Rev Mol Med       Date:  2010-06-29       Impact factor: 5.600

9.  Beyond amyloid: getting real about nonamyloid targets in Alzheimer's disease.

Authors:  Karl Herrup; Maria C Carrillo; Dale Schenk; Angela Cacace; Susan Desanti; Robert Fremeau; Ratan Bhat; Marcie Glicksman; Patrick May; Russell Swerdlow; Linda J Van Eldik; Lisa J Bain; Samantha Budd
Journal:  Alzheimers Dement       Date:  2013-07       Impact factor: 21.566

10.  The tsA58 simian virus 40 large tumor antigen disrupts megakaryocyte differentiation in transgenic mice.

Authors:  M O Robinson; W Zhou; M Hokom; D M Danilenko; R Y Hsu; R E Atherton; W Xu; S Mu; C J Saris; S Swift
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.